Hepatobiliary enhancement with Gd-EOB-DTPA: Comparison of spin-echo and STIR imaging for detection of experimental liver metastases

Radiology

Volumn 184, Issue 1, 1992, Pages 207-213

  Mühler, Andreas ^a   Clément, Olivier ^a   Vexler, Vladimir ^a   Berthezène, Yves ^a   Rosenau, Werner ^a   Brasch, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contrast media, experimental studies; Gadolinium; Liver, MR, 761.1214; Magnetic resonance (MR), contrast enhancement; Magnetic resonance (MR), relaxometry

Indexed keywords

GADOLINIUM PENTETATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; DRUG ELIMINATION; DUODENUM; FEMALE; GALLBLADDER; HISTOPATHOLOGY; INTERMETHOD COMPARISON; KIDNEY CLEARANCE; LIVER CLEARANCE; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT;

ACETIC ACIDS; ANIMAL; BILE; COMPARATIVE STUDY; CONTRAST MEDIA; DUODENUM; EDETIC ACID; FEMALE; GADOLINIUM; GALLBLADDER; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MODELS, STATISTICAL; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; PYRIDOXAL PHOSPHATE; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0026729113     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.184.1.1609081     Document Type: Article

References (30)

1. Yoshida H, Itai Y, Ohtomo K, Kokuba T, Minami M, Yashiro N. Small hepatocellular carcinoma and cavernous hemangioma: differentiation with dynamic FLASH MR imaging with Gd-DTPA. Radiology 1989; 171:339-342.
2. Hamm B, Wolf KJ, Felix R. Conventional and rapid MR imaging of the liver with Gd-DTPA. Radiology 1987; 164:313-320.
3. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183:59-64.
4. Clément O, Mühler A, Vexier V, Berthezène Y, Brasch RC. Gd-EOB-DTPA, a new liver-specific MR contrast agent: relaxivity, kinetics and enhancement patterns in normal rats (abstr). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1991. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1991; 1047.
5. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 1991; 22:233-237.
6. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR 1984; 142:619-624.
7. Tsang YM, Stark DD, Chen MCM, Weissleder R, Wittenberg J, Ferrucci JT. Hepatic micrometastases in the rat: ferrite-enhanced MR imaging. Radiology 1988; 167: 21-24.
8. Fleckenstein JL, Archer BT, Barker BA, Vaughan JT, Parkey RW, Peshock RM. Fast short-tau inversion-recovery MR imaging. Radiology 1991; 179:499-504.
9. Young SW, Bradley B, Muller H, Rubin DL. Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent. Magn Reson Imaging 1990; 8:267-276.
10. Cavagna F, Tirone P, Felder E, de Haën C. Gd-BOPTA/dimeg, a new hepatobiliary contrast agent for magnetic resonance imaging. In: Katayama H, Brasch RC, eds. New dimensions of contrast media. III. MRI contrast media. Tokyo: Excerpta Medica, 1991; 83-94.
11. Dousset M, Weissleder R, Hendrick RE, et al. Short TI inversion-recovery imaging of the liver: pulse-sequence optimization and comparison with spin-echo imaging. Radiology 1989; 171:327-333.
12. Tweedle MF, Wedeking P, Telser J, et al. Dependence of MR signal intensity on Gd tissue concentration over a broad dose range. Magn Reson Med 1991; 22:191-194.
13. Silverman PM, Feuerstein IM, Garra BS, Zeman RK. Evaluation of STIR imaging as a complement to spin-echo MR and CT of the porta hepatis/hepatoduodenal ligament. Magn Reson Imaging 1991; 9:73-77.
14. Shuman WP, Baron RL, Peters MJ, Tazioli PK. Comparison of STIR and spin-echo MR imaging at 1.5 T in 90 lesions of the chest, liver, and pelvis. AJR 1989; 152:853-859.
15. Bydder GM, Steiner RE, Blumgart LH, Khenia S, Young IR. MR imaging of the liver using short TI inversion recovery sequences. J Comput Assist Tomogr 1985; 9:1084-1089.
16. Dwyer AJ, Frank JA, Sank VJ, Reinig JW, Hickey AM, Doppman JL. Short-TI inversion-recovery pulse sequence: analysis and initial experience in cancer imaging. Radiology 1988; 168:827-836.
17. Lehmann B, Fanucci E, Gigli F, Uhlenbrock D, Bartolozzi C. Signal suppression of normal liver tissue by phase corrected inversion recovery: a screening technique. J Comput Assist-Tomogr 1989; 13:650-655.
18. Mihara F, Gupta KL. Gd-DTPA-enhanced short repetition time and short inversion time inversion recovery magnetic resonance imaging: experimental and clinical assessment. Invest Radiol 1991; 8:734-741.
19. Gandon Y, Heautot JF, Brunet F, Guyader D, Deugnier Y, Carsin M. Superparamagnetic iron oxide: clinical time-response study. Eur J Radiol 1991; 12:195-200.
20. Edelman RR, Siegel JB, Singer A, Dupuis K, Longmaid HE. Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results. AJR 1989; 153:1213-1219.
21. Young SW. MR contrast media for hepatic imaging. Proceedings of the UCSF workshop clinical MR imaging in San Francisco, 1990; 412-414.
22. Hamm B, Vogl TJ, Branding G, et al. Focal liver lesions: MR imaging with Mn-DPDP-initial clinical results in 40 patients. Radiology 1992; 182:167-174.
23. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991; 178:73-78.
24. Cavagna F, Tirone P, Felder E, de Haën C. Hepatobiliary contrast agents for magnetic resonance imaging. In: Ferrucci JT, Stark DD, eds. Liver imaging: current trends. Andover, Mass: Medical Publishers, 1990; 383-401.
25. Pavone P, Patrizio G, Buoni C, et al. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver. Radiology 1990; 176:61-64.
26. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR 1990; 155:943-950.
27. Marchal G, van Hecke P, Demaerel P, et al. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. AJR 1989; 152: 771-775.
28. Van Hecke P, Marchai G, Decrop E, Baert AL. Experimental study of the pharmacokinetics and dose response of ferrite particles used as a contrast agent in MRI of the normal liver of the rabbit. Invest Radiol 1989; 24:397-399.
29. Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR 1989; 152:167-173.
30. Doucet D, Chambon C, Mayer D. Superparamagnetic contrast agents: effect on MR signals. In: Rinck PA, Muller RN, eds. New developments in contrast agent research: congress proceedings of the European workshop on magnetic resonance in medicine. Bordeaux, France; 1990; 26-32.